influenza

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Cidara gets $339m BARDA award for flu prophylactic

Cidara is celebrating a major injection of funding from the US government for its experimental one-shot, universal flu prophylactic CD388.

News

Sanofi faces EU antitrust probe into vaccine business

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

News

Moderna shines spotlight on new flu vaccine data

Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes.

News

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology.

News

FDA chooses flu vaccine strains despite cancelled meeting

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Cidara gets $339m BARDA award for flu prophylactic

Sanofi faces EU antitrust probe into vaccine business

Moderna shines spotlight on new flu vaccine data

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

FDA chooses flu vaccine strains despite cancelled meeting

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

influenza

Editor's Picks